Exploiting TGF-β-mediated Stromal Programming in Homologous Recombination-Deficient Pancreatic Cancer
Élodie Roger, Hannah M Mummey, Eleni Zimmer, Dharini Srinivasan, Anna Härle, Loïc Moubri, Alica K. Beutel, Rima Singh, Menar Ekizce, Michael Karl Melzer, Yun Jung Lee, Austin Silva, Luisa Härle, Thomas Engleitner, Frank Arnold, , Alexander Kleger
This study shows that ATM-deficient pancreatic cancers reprogram the tumor microenvironment via TGF-β-driven myCAF enrichment, and targeting this stromal axis with chemotherapy improves therapeutic efficacy.
bioRxiv · Sep 16, 2025 · PreprintCancer Biology